ASH81, offers usually have a takeover premium, especially if multiple bidders, so why would this result in a sell-off ? or are you expecting a low ball offer
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%